OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 97
- −9 vs. Q1 2025
- Portfolio value
- $3.98B
- −$187.0M (−4.5%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Lakeshore Biopharma Co LtdG9845F208 | ORD SHS NEW | 54,799 | $55.9K | <0.1% | −85,629−61.0% | Reduced | – |
| XERSXeris Biopharma Holdings, Inc. | COM | 80,420 | $375.6K | <0.1% | 00.0% | Unchanged | History |
| KRROKorro Bio, Inc. | COM | 32,400 | $404.7K | <0.1% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 51,727 | $457.3K | <0.1% | +51,727 | New | History |
| DHAIDih Holding US, Inc. | CL A | 1,915,000 | $469.0K | <0.1% | 00.0% | Unchanged | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 250,000 | $550.0K | <0.1% | 00.0% | Unchanged | History |
| KZRKezar Life Sciences, Inc. | COM | 192,700 | $882.6K | <0.1% | 00.0% | Unchanged | History |
| TRAWTraws Pharma, Inc. | COM NEW | 605,531 | $896.2K | <0.1% | 00.0% | Unchanged | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 940,990 | $1.09M | <0.1% | −800,283−46.0% | Reduced | History |
| TSBXTurnstone Biologics Corp. | COM | 3,099,265 | $1.11M | <0.1% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 9,200 | $1.26M | <0.1% | −14,300−60.9% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 13,459 | $1.35M | <0.1% | −15,200−53.0% | Reduced | History |
| MURAMural Oncology plc | ORD SHS | 588,800 | $1.45M | <0.1% | +588,800 | New | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 313,200 | $2.01M | 0.1% | −34,800−10.0% | Reduced | History |
| PASGPassage BIO, Inc. | COM | 6,055,300 | $2.42M | 0.1% | −979,326−13.9% | Reduced | History |
| ENGNenGene Therapeutics Inc. | COM | 677,977 | $2.47M | 0.1% | −213,639−24.0% | Reduced | History |
| QTTBQ32 Bio Inc. | COM | 2,252,987 | $3.36M | 0.1% | 00.0% | Unchanged | History |
| BIOABioAge Labs, Inc. | COM | 921,959 | $3.81M | 0.1% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 719,901 | $3.87M | 0.1% | −2,367,561−76.7% | Reduced | History |
| RPTXRepare Therapeutics Inc. | COM | 3,322,488 | $4.62M | 0.1% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 3,539,358 | $4.74M | 0.1% | 00.0% | Unchanged | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 967,000 | $4.83M | 0.1% | 00.0% | Unchanged | History |
| NSPRInspireMD, Inc. | COM | 2,133,405 | $4.84M | 0.1% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM NEW | 531,163 | $5.31M | 0.1% | +531,163 | New | History |
| ALMSAlumis Inc. | COM | 1,926,423 | $5.78M | 0.1% | +1,926,423 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 34,400 | $5.94M | 0.1% | +34,400 | New | History |
| URGNUroGen Pharma Ltd. | COM | 478,400 | $6.55M | 0.2% | +478,400 | New | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 6,475,291 | $6.86M | 0.2% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 700,000 | $6.98M | 0.2% | +700,000 | New | History |
| ACETAdicet Bio, Inc. | COM | 11,447,140 | $6.98M | 0.2% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 804,603 | $7.70M | 0.2% | −948,228−54.1% | Reduced | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 4,166,000 | $7.79M | 0.2% | 00.0% | Unchanged | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 197,900 | $8.02M | 0.2% | −455,843−69.7% | Reduced | History |
| ZLABZai Lab Ltd | ADR | 231,000 | $8.08M | 0.2% | +231,000 | New | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 1,172,287 | $8.09M | 0.2% | 00.0% | Unchanged | History |
| PRLDPrelude Therapeutics Inc | COM | 10,909,256 | $8.83M | 0.2% | 00.0% | Unchanged | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 416,900 | $9.05M | 0.2% | +416,900 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 899,281 | $9.13M | 0.2% | +199,281+28.5% | Added | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 6,830,300 | $9.77M | 0.2% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 1,031,400 | $9.82M | 0.2% | +16,789+1.7% | Added | History |
| MLYSMineralys Therapeutics, Inc. | COM | 760,351 | $10.3M | 0.3% | +760,351 | New | History |
| AKROAkero Therapeutics, Inc. | COM | 211,300 | $11.3M | 0.3% | +31,400+17.5% | Added | History |
| ABCLAbCellera Biologics Inc. | COM | 3,344,568 | $11.5M | 0.3% | −836,200−20.0% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 2,380,715 | $12.0M | 0.3% | +132,466+5.9% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,285,400 | $13.1M | 0.3% | 00.0% | Unchanged | History |
| 0000000000 | Stock | 12,048,773 | $13.1M | 0.3% | 00.0% | Unchanged | – |
| RAPTRAPT Therapeutics, Inc. | COM NEW | 1,641,906 | $13.1M | 0.3% | +1,641,906 | New | History |
| KROSKeros Therapeutics, Inc. | COM | 1,018,734 | $13.6M | 0.3% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,923,855 | $14.5M | 0.4% | 00.0% | Unchanged | History |
| FBRXForte Biosciences, Inc. | COM NEW | 1,196,955 | $15.5M | 0.4% | +603,867+101.8% | Added | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 248,512 | $15.7M | 0.4% | −131,488−34.6% | Reduced | History |
| ADCTADC Therapeutics SA | SHS | 5,907,351 | $15.8M | 0.4% | −61,100−1.0% | Reduced | History |
| TRVITrevi Therapeutics, Inc. | COM | 3,308,400 | $18.1M | 0.5% | +2,188,400+195.4% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 557,900 | $18.6M | 0.5% | +232,400+71.4% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 46,500 | $18.9M | 0.5% | −82,500−64.0% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 8,461,500 | $19.2M | 0.5% | +8,461,500 | New | History |
| SCPHscPharmaceuticals Inc. | COM | 6,059,528 | $23.1M | 0.6% | 00.0% | Unchanged | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 1,199,300 | $24.9M | 0.6% | +547,272+83.9% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,482,300 | $25.7M | 0.6% | +50,000+3.5% | Added | History |
| JANXJanux Therapeutics, Inc. | COM | 1,210,300 | $28.0M | 0.7% | +451,734+59.6% | Added | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 7,562,971 | $28.2M | 0.7% | 00.0% | Unchanged | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 7,165,006 | $28.7M | 0.7% | +221,352+3.2% | Added | History |
| NPCENeuroPace Inc | COM | 2,614,184 | $29.1M | 0.7% | −792,151−23.3% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 947,877 | $29.7M | 0.7% | 00.0% | Unchanged | History |
| ROIVRoivant Sciences Ltd. | SHS | 2,779,427 | $31.3M | 0.8% | +2,779,427 | New | History |
| THRDThird Harmonic Bio, Inc. | COM | 5,779,071 | $31.4M | 0.8% | 00.0% | Unchanged | History |
| EXASExact Sciences Corp | COM | 607,316 | $32.3M | 0.8% | −72,500−10.7% | Reduced | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,149,000 | $33.0M | 0.8% | +150,000+15.0% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 1,077,000 | $35.6M | 0.9% | −432,205−28.6% | Reduced | History |
| CMPXCompass Therapeutics, Inc. | COM | 15,219,994 | $39.6M | 1.0% | −7,142,856−31.9% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 427,900 | $44.7M | 1.1% | +41,200+10.7% | Added | History |
| MBXMBX Biosciences, Inc. | COM | 4,002,887 | $45.7M | 1.1% | 00.0% | Unchanged | History |
| SIBNSI-BONE, Inc. | COM | 2,578,979 | $48.5M | 1.2% | −863,874−25.1% | Reduced | History |
| CGONCG Oncology, Inc. | COM | 1,877,850 | $48.8M | 1.2% | −594,144−24.0% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,812,886 | $51.5M | 1.3% | 00.0% | Unchanged | – |
| ITGRInteger Holdings Corp | COM | 433,400 | $53.3M | 1.3% | −229,100−34.6% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 438,540 | $55.1M | 1.4% | −496,100−53.1% | Reduced | History |
| UPBUpstream Bio, Inc. | COM | 5,693,589 | $62.5M | 1.6% | 00.0% | Unchanged | History |
| SIONSionna Therapeutics, Inc. | COM | 3,704,959 | $64.3M | 1.6% | 00.0% | Unchanged | History |
| AVBPArriVent BioPharma, Inc. | COM | 3,027,328 | $65.9M | 1.7% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 1,415,020 | $74.9M | 1.9% | 00.0% | Unchanged | History |
| CAICaris Life Sciences, Inc. | COM | 3,034,858 | $81.1M | 2.0% | +3,034,858 | New | History |
| THCTenet Healthcare Corp | COM NEW | 465,000 | $81.8M | 2.1% | 00.0% | Unchanged | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 210,287 | $93.6M | 2.4% | +50,387+31.5% | Added | History |
| NTRANatera, Inc. | COM | 593,434 | $100.3M | 2.5% | +46,434+8.5% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 336,300 | $104.9M | 2.6% | +135,100+67.1% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 341,900 | $111.5M | 2.8% | −4,200−1.2% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 208,000 | $114.7M | 2.9% | +1,300+0.6% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 1,708,000 | $133.6M | 3.4% | +176,000+11.5% | Added | History |
| SYKStryker Corp | Stock | 359,200 | $142.1M | 3.6% | 00.0% | Unchanged | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 8,288,510 | $144.6M | 3.6% | 00.0% | Unchanged | History |
| ISRGIntuitive Surgical Inc | COM NEW | 291,000 | $158.1M | 4.0% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 7,959,538 | $159.7M | 4.0% | 00.0% | Unchanged | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 15,518,492 | $203.4M | 5.1% | +496,771+3.3% | Added | History |
| LLYEli Lilly & Co | Stock | 337,600 | $263.2M | 6.6% | 00.0% | Unchanged | History |
| BSXBoston Scientific Corp | Stock | 2,813,200 | $302.2M | 7.6% | 00.0% | Unchanged | History |
| SVASinovac Biotech Ltd | SHS | 2,718,735 | $334.0M | 8.4% | 00.0% | Unchanged | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2025 (23)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| PFEPfizer Inc | Stock | 3,850,200 | $97.6M | 2.3% | History |
| IONSIonis Pharmaceuticals Inc | COM | 2,540,136 | $76.6M | 1.8% | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 950,200 | $41.9M | 1.0% | History |
| XTNTXtant Medical Holdings, Inc. | COM NEW | 73,114,592 | $34.4M | 0.8% | History |
| GILDGilead Sciences, Inc. | Stock | 197,500 | $22.1M | 0.5% | History |
| VSTMVerastem, Inc. | COM NEW | 2,862,448 | $17.3M | 0.4% | History |
| RAPTRAPT Therapeutics, Inc. | COM | 13,135,260 | $16.0M | 0.4% | History |
| AMGNAmgen Inc | Stock | 44,200 | $13.8M | 0.3% | History |
| VERAVera Therapeutics, Inc. | CL A | 481,065 | $11.6M | 0.3% | History |
| SLRNACELYRIN, Inc. | COM | 4,001,711 | $9.88M | 0.2% | History |
| KMTSKestra Medical Technologies, Ltd. | SHS | 250,000 | $6.23M | 0.1% | History |
| SRRKScholar Rock Holding Corp | COM | 151,800 | $4.88M | 0.1% | History |
| BCAXBicara Therapeutics Inc. | COM | 298,301 | $3.89M | 0.1% | History |
| CBLLCeribell, Inc. | COM | 112,500 | $2.16M | 0.1% | History |
| TILInstil Bio, Inc. | COM NEW | 116,785 | $2.03M | <0.1% | History |
| CRDFCardiff Oncology, Inc. | COM | 573,884 | $1.80M | <0.1% | History |
| XFORX4 Pharmaceuticals, Inc | COM | 6,776,515 | $1.60M | <0.1% | History |
| NKTXNkarta, Inc. | COM | 821,400 | $1.51M | <0.1% | History |
| FATEFate Therapeutics Inc | COM | 1,680,580 | $1.33M | <0.1% | History |
| HLSQTessera Defense & Homeland Security Inc. | COM NEW | 1,787,767 | $993.5K | <0.1% | History |
| TNGXTango Therapeutics, Inc. | COM | 550,000 | $753.5K | <0.1% | History |
| IVVDInvivyd, Inc. | COM | 933,500 | $565.0K | <0.1% | History |
| NXTCNextCure, Inc. | COM | 1,141,200 | $548.1K | <0.1% | History |